These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2727573)

  • 21. Mental disorders in Parkinson's disease after treatment with L-DOPA.
    Rondot P; de Recondo J; Coignet A; Ziegler M
    Adv Neurol; 1984; 40():259-69. PubMed ID: 6695602
    [No Abstract]   [Full Text] [Related]  

  • 22. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Depression and Parkinson's Disease: study of a series of 135 Parkinson's patients].
    Anguenot A; Loll PY; Neau JP; Ingrand P; Gil R
    Can J Neurol Sci; 2002 May; 29(2):139-46. PubMed ID: 12038469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difficulties in long term management of Parkinson's disease.
    Burns R
    Aust Fam Physician; 1984 May; 13(5 Suppl):14-6. PubMed ID: 6497765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic-dependent cognitive deficits in Parkinson's disease.
    Dubois B; Danzé F; Pillon B; Cusimano G; Lhermitte F; Agid Y
    Ann Neurol; 1987 Jul; 22(1):26-30. PubMed ID: 3631918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of mental disorders in persons with Parkinson's disease].
    de Rijk C; Bijl RV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of behavioral disorders in Parkinson's disease.
    Valldeoriola F; Molinuevo J
    Biomed Pharmacother; 1999 Apr; 53(3):149-53. PubMed ID: 10349504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cognitive deterioration in Parkinson's disease].
    Perea-Bartolomé MV
    Rev Neurol; 2001 Jun 16-30; 32(12):1182-7. PubMed ID: 11562851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive and behavioural impairment in Parkinson's disease.
    Merims D; Freedman M
    Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cognitive and behavioral disorders in Parkinson disease].
    Pascual-Leone A; Press D
    Rev Neurol; 1999 Jul 16-31; 29(2):152-7. PubMed ID: 10528330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychiatric and cognitive symptoms in Parkinson disease].
    Aarsland D; Pedersen KF; Ehrt U; Bronnick K; Gjerstad MD; Larsen JP
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2072-6. PubMed ID: 18846124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.